Cumberland Pharmaceuticals
CPIX
45 hedge funds and large institutions have $31.4M invested in Cumberland Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 18 reducing their positions, and 5 closing their positions.
4% more capital invested
Capital invested by funds: $30.1M → $31.4M (+$1.28M)
0% more funds holding
Funds holding: 45 → 45 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
67% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$337K |
| 2 |
AIS
AlphaOne Investment Services
West Chester,
Pennsylvania
|
+$142K |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$43.9K |
| 4 |
Renaissance Technologies
New York
|
+$35.3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$20.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KIM
Kestrel Investment Management
San Mateo,
California
|
-$619K |
| 2 |
LSV Asset Management
Chicago,
Illinois
|
-$450K |
| 3 |
AI
Ariel Investments
Chicago,
Illinois
|
-$271K |
| 4 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
-$204K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$142K |
CPIX Hedge Fund Activity: Q3 2014 in Review
45 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q3 2014, worth a combined $31.4M — up 4.3% from $30.1M a quarter earlier.
Fund positioning in CPIX was balanced in Q3 2014: 5 funds opened new positions, 5 closed out, 6 added to existing stakes and 18 trimmed.
The largest buyer was Millennium Management, adding an estimated $337K. The largest seller was Kestrel Investment Management, exiting entirely with an estimated $619K sold.
- 45 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q3 2014, unchanged from Q2 2014.
- Funds reported $31.4M of Cumberland Pharmaceuticals stock for Q3 2014, up 4.3% quarter-over-quarter.
- 5 funds opened new Cumberland Pharmaceuticals positions in Q3 2014 and 5 closed out, a net change of 0 holders.
- The largest Cumberland Pharmaceuticals buyer in Q3 2014 was Millennium Management, an estimated $337K added.
- The largest Cumberland Pharmaceuticals seller in Q3 2014 was Kestrel Investment Management, an estimated $619K sold.
Based on aggregated 13F filings for Q3 2014.